Clinical Cancer Research

ANNOUNCING SPECIAL OPPORTUNITY: Patient Directed Clinical Trials September 27, 2021 This year the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) is celebrating its 10-year anniversary. In parallel, Swiss Cancer Research (SCR) is having a 30-year celebration. To mark these milestones, we are launching a joint call for proposals to fund a jubilee award. This award seeks to provide funding to support […]

Rising Tide Team goes Schaffhauser Stadtlauf September 9, 2021 On Sunday, September 5 members of our Rising Tide team did participate in the 3. Schaffhauser Stadtlauf. With our run we support the Brave like Gabe initiative. Gabriele Grunewald was a professional runner and rare cancer advocate. She founded the Brave Like Gabe Foundation to encourage others

27 clinical studies in pancreatic cancer are on our radar August 18, 2021 We have received 27 applications to our call for projects in pancreatic and biliary tract cancer, announced earlier this year. This Request for Application (RFA) is a joint initiative by the Anticancer Fund and the Rising Tide Foundation for Clinical Cancer Research, a Swiss non-profit organisation.

Setting the Groundwork for Patient-Centric 1st in Human Clinical Trial Funding Opportunities August 11, 2021 Rising Tide Foundation for Clinical Cancer Research operates with the goal of helping patients improve their quality of life and win the fight against cancer. In 2017, Melanoma Research Alliance and RTFCCR joined forces to fund a European-led Team Science Award (TSA). In 2019, the

Managing Symptoms for Patients: A Call to Study Supportive Care July 28, 2021 We are proud to share this interview touching on one of our focus areas – symptom management. Kudos to our collaboration partners ASCO and Conquer Cancer. Interview with Dr. Lage – by Jennifer Temel, MD More about the collaboration between the Rising

RTFCCR and Patvocates collaborate to enhance patient engagement in cancer research projects July 7, 2022 Over the past two years, the Rising Tide Foundation for Clinical Cancer Research, a philanthropic funder of clinical cancer research, partnered with Patvocates to identify gaps in patient engagement in cancer research projects. The goal was to understand how funding institutions can encourage

TRIAL UPDATE: First patient was enrolled in the EORTC 1945 July 1, 2021 OligoRARE trial in oligometastatic rare cancers OligoRARE is an international study with 6 participating countries in Europe and a collaboration with the British Columbia Cancer Agency in Canada.  EORTC would like to thank The Anticancer Fund and Rising Tide Group for supporting

RTFCCR and ACF Joint Request for Application: pancreatic and biliary tract cancer April 30, 2021 The Anticancer Fund and the Rising Tide Foundation decided to join forces for this call as there is a need and urge to find new treatment options for patients with pancreatic cancer. Despite all recent innovation in cancer therapies, pancreatic

COVID-19 & Cancer: Latest research news for patients April 14, 2021 Rising Tide Foundation for Clinical Cancer Research is proudly supporting the Patient Forum: COVID-19 & Cancer – an online event organized by SAKK (Swiss Association for Clinical Cancer Research) that aims to inform cancer patients and their families about risks associated with the current pandemic. Do